If I switch from Ozempic to tirzepatide, how soon should A1C change?

The short version: after switching from Ozempic to tirzepatide, you should expect to see meaningful A1C change within 8 to 12 weeks, with the full effect by about 6 months.

The SURPASS trials, which are manufacturer-funded, found that tirzepatide reduced HbA1c by 1.69 to 2.58 percentage points across doses of 5 to 15 mg weekly [2]. Those reductions were measured at 40 to 52 weeks, but the mechanism tells you the early timeline. A1C reflects average blood glucose over the prior 2 to 3 months, so the first detectable drop appears around 4 weeks, and the bulk of the change shows up by the 8- to 12-week mark. The 2026 systematic review confirms that tirzepatide outperformed semaglutide 1.0 mg on both HbA1c and weight [1].

What matters for you specifically: you are already on semaglutide, so your baseline A1C is likely lower than the trial populations' starting points. The absolute drop will be smaller than the 1.7 to 2.6 points seen in people starting from higher baselines. But the relative improvement over staying on Ozempic is real. In the phase 1 mechanistic study, tirzepatide improved insulin sensitivity by 65.7% compared to 37.5% with semaglutide [2]. That is a 20.5% greater improvement in how your body handles glucose, and it starts working from the first dose.

No trial has studied this exact switch in plateaued patients, so the timeline is inferred from the pharmacology. A1C is a lagging measure: it takes about 2 weeks for the first meaningful change to register on a lab test, and the full effect of the dose you settle on appears by 5 to 6 months. If you test at 3 months and see no movement, the dose may be too low or the switch may not be right for you.

My call: expect a measurable A1C drop by 8 to 12 weeks, with the full effect by 6 months. Confidence: moderate, because the pharmacology is well understood but no trial has tested this exact scenario.